medigraphic.com

2018, Number 3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2018; 56 (3)

Multicentric insulinoma associated with multiple endocrine neoplasia type 1: One case report

Gamboa-Jiménez TI, Juárez-Aguilar FG

Language: Spanish
References: 15
Page: 316-319
PDF size: 950.12 Kb.


ABSTRACT

Background: Pancreatic neuroendocrine tumors may be associated with multiple endocrine neoplasia type 1 (MEN1) in 15-25% of cases, and up to 10% develop insulinomas, which are the most frequent cause of persistent hyperinsulinemic hypoglycemia in adults. The objective is to show a clinical case that presents this association.
Clinical case: 36-year-old patient with seizures associated with fasting hypoglycemia of 36 mg/dL. The patient presented high levels of insulin, peptide C, proinsulin, hypercalcemia, hypophosphatemia and parathyhroid hormone. Ultrasound sonography test showed hypoechoic lesion in the pancreatic tail of 2.3 cm. Tomography showed a 10 mm hypodense lesion at pancreatic head. Scintigram showed hypercaptating parathyroid tissue. Magnetic resonance did not show evidence of pituitary adenoma. We carried out a tumor enucleation of the pancreatic head and distal partial pancreatectomy with histopathological diagnosis of welldifferentiated low-grade multifocal neuroendocrine tumor (five tumors); two tumors were immunoreactive to insulin. After surgery, glucose level was normalized (105 mg/dL). Patient underwent parathyroidectomy with a report of adenoma of the parathyroid gland.
Conclusion: The multicentricity of pancreatic neuroendocrine tumors related to parathyroid neoplasia suggests the diagnosis of MEN1. Genetic molecular studies should be performed to confirm this and provide the patient with a correct diagnosis, targeted treatment and adequate genetic counseling.


REFERENCES

  1. Klöpple G. Tumor of the endocrine pancreas. In: Fletcher CDM, ed. Diagnostic histopathology of tumors. 2 Volume Set, 4th Edition. Philadelphia, PA, USA: Elsevier Saunders; 2013. pp. 1326-42.

  2. Pérez-De Nanclares G. Neoplasia endócrina múltiple: estudio genético. Endócrinol Nutr. 2005;52(5):199-201.

  3. Wohllk GN, Díaz TR. Neoplasias endócrinas múltiples. Desde el laboratorio al paciente. Rev Med Clin Condes. 2013;24(5),778-83.

  4. Anlauf M, Bauersfeld J, Raffel A, Koch CA, Henopp T, Alkatout I, et al. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia. Am J Surg Pathol. 2009 Mar;33(3):339-46.

  5. Priego P, Sanjuanbenito A, Martinez-Molina E, Lobo,E, Garcia-Teruel D, Morales V et al. Manejo diagnóstico y terapeútico del insulinoma pancréatico. Rev Esp Enferm. 2007;99(4),218-22.

  6. Shin JJ, Gorden P, Libutti SK. Insulinoma: pathophysiology, localization and management. Future Oncol. 2010;6(2):229-37.

  7. Marini F, Falchetti A, Del Monte F, Carbonell Sala S, Gozzini A, Luzi E, et al. Multiple endocrine neoplasia type 1. Orphanet J Rare Dis. 2006 Oct 2;1:38.

  8. Thakker RV. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol. 2014 Apr 5; 386(1-2): 2-15.

  9. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, et al. Clinical studies of multiple endocrine 2 neoplasia type 1 (MEN1). QJM. 1996 Sep;89(9):653-69.

  10. Bassett JH, Forbes SA, Pannett AA, Lloyd SE, Christie PT, Wooding C, et al. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet. 1998 Feb;62(2):232-44.

  11. Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013 Feb 14;19(6):829-37.

  12. Iglesias P, Díez JJ. Management of endocrine disease: a clinical update on tumor-induced hypoglycemia. Eur J Endocrinol. 2014 Mar 14;170(4):R147-57.

  13. Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012 Sep;97(9):2990-3011.

  14. Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau JW, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab. 2009 Apr;94(4):1069-73.

  15. Turner JJ, Christie PT, Pearce SH, Turnpenny PD, Thakker RV. Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1). Hum Mutat. 2010 Jan;31(1):E1089-101.




2020     |     www.medigraphic.com